242 related articles for article (PubMed ID: 32768522)
1. Reactivation of BMP signaling by suboptimal concentrations of MEK inhibitor and FK506 reduces organ-specific breast cancer metastasis.
Ren J; Wang Y; Ware T; Iaria J; Ten Dijke P; Zhu HJ
Cancer Lett; 2020 Nov; 493():41-54. PubMed ID: 32768522
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a natural small-molecule compound that suppresses tumor EMT, stemness and metastasis by inhibiting TGFβ/BMP signaling in triple-negative breast cancer.
Di L; Liu LJ; Yan YM; Fu R; Li Y; Xu Y; Cheng YX; Wu ZQ
J Exp Clin Cancer Res; 2019 Mar; 38(1):134. PubMed ID: 30898152
[TBL] [Abstract][Full Text] [Related]
3. Methylglyoxal, a glycolysis metabolite, triggers metastasis through MEK/ERK/SMAD1 pathway activation in breast cancer.
Nokin MJ; Bellier J; Durieux F; Peulen O; Rademaker G; Gabriel M; Monseur C; Charloteaux B; Verbeke L; van Laere S; Roncarati P; Herfs M; Lambert C; Scheijen J; Schalkwijk C; Colige A; Caers J; Delvenne P; Turtoi A; Castronovo V; Bellahcène A
Breast Cancer Res; 2019 Jan; 21(1):11. PubMed ID: 30674353
[TBL] [Abstract][Full Text] [Related]
4. PTEN sensitizes MDA-MB-468 cells to inhibition of MEK/Erk signaling for the blockade of cell proliferation.
Jang K; Kim M; Seo HS; Shin I
Oncol Rep; 2010 Sep; 24(3):787-93. PubMed ID: 20664988
[TBL] [Abstract][Full Text] [Related]
5. BMP-6 promotes E-cadherin expression through repressing deltaEF1 in breast cancer cells.
Yang S; Du J; Wang Z; Yuan W; Qiao Y; Zhang M; Zhang J; Gao S; Yin J; Sun B; Zhu T
BMC Cancer; 2007 Nov; 7():211. PubMed ID: 17997862
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of BMP and of TGFβ receptors downregulates expression of XIAP and TAK1 leading to lung cancer cell death.
Augeri DJ; Langenfeld E; Castle M; Gilleran JA; Langenfeld J
Mol Cancer; 2016 Apr; 15():27. PubMed ID: 27048361
[TBL] [Abstract][Full Text] [Related]
7. Preclinical Evaluation of AZ12601011 and AZ12799734, Inhibitors of Transforming Growth Factor
Spender LC; Ferguson GJ; Hughes GD; Davies BR; Goldberg FW; Herrera B; Taylor RG; Strathearn LS; Sansom OJ; Barry ST; Inman GJ
Mol Pharmacol; 2019 Feb; 95(2):222-234. PubMed ID: 30459156
[TBL] [Abstract][Full Text] [Related]
8. A novel and selective inhibitor of PKC ζ potently inhibits human breast cancer metastasis in vitro and in mice.
Wu J; Liu S; Fan Z; Zhang L; Tian Y; Yang R
Tumour Biol; 2016 Jun; 37(6):8391-401. PubMed ID: 26733166
[TBL] [Abstract][Full Text] [Related]
9. Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway.
Katsuno Y; Hanyu A; Kanda H; Ishikawa Y; Akiyama F; Iwase T; Ogata E; Ehata S; Miyazono K; Imamura T
Oncogene; 2008 Oct; 27(49):6322-33. PubMed ID: 18663362
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of breast cancer metastases by a novel inhibitor of TGFβ receptor 1.
Fang Y; Chen Y; Yu L; Zheng C; Qi Y; Li Z; Yang Z; Zhang Y; Shi T; Luo J; Liu M
J Natl Cancer Inst; 2013 Jan; 105(1):47-58. PubMed ID: 23178439
[TBL] [Abstract][Full Text] [Related]
11. Smad6 determines BMP-regulated invasive behaviour of breast cancer cells in a zebrafish xenograft model.
de Boeck M; Cui C; Mulder AA; Jost CR; Ikeno S; Ten Dijke P
Sci Rep; 2016 Apr; 6():24968. PubMed ID: 27113436
[TBL] [Abstract][Full Text] [Related]
12. Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status.
Chao MW; Chang LH; Tu HJ; Chang CD; Lai MJ; Chen YY; Liou JP; Teng CM; Pan SL
Clin Epigenetics; 2019 May; 11(1):85. PubMed ID: 31142371
[TBL] [Abstract][Full Text] [Related]
13. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
14. Apple Peel Flavonoid Fraction 4 Suppresses Breast Cancer Cell Growth by Cytostatic and Cytotoxic Mechanisms.
Loung CY; Fernando W; Rupasinghe HPV; Hoskin DW
Molecules; 2019 Sep; 24(18):. PubMed ID: 31540221
[TBL] [Abstract][Full Text] [Related]
15. BMP-6 inhibits the metastasis of MDA-MB-231 breast cancer cells by regulating MMP-1 expression.
Hu F; Zhang Y; Li M; Zhao L; Chen J; Yang S; Zhang X
Oncol Rep; 2016 Mar; 35(3):1823-30. PubMed ID: 26751737
[TBL] [Abstract][Full Text] [Related]
16. Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression.
Ren J; Smid M; Iaria J; Salvatori DCF; van Dam H; Zhu HJ; Martens JWM; Ten Dijke P
Breast Cancer Res; 2019 Sep; 21(1):109. PubMed ID: 31533776
[TBL] [Abstract][Full Text] [Related]
17. Role of Smad1 and Smad4 proteins in the induction of p21WAF1,Cip1 during bone morphogenetic protein-induced growth arrest in human breast cancer cells.
Pouliot F; Labrie C
J Endocrinol; 2002 Jan; 172(1):187-98. PubMed ID: 11786386
[TBL] [Abstract][Full Text] [Related]
18. U0126 inhibits pancreatic cancer progression via the KRAS signaling pathway in a zebrafish xenotransplantation model.
Guo M; Wei H; Hu J; Sun S; Long J; Wang X
Oncol Rep; 2015 Aug; 34(2):699-706. PubMed ID: 26035715
[TBL] [Abstract][Full Text] [Related]
19. Dasatinib synergizes with both cytotoxic and signal transduction inhibitors in heterogeneous breast cancer cell lines--lessons for design of combination targeted therapy.
Park BJ; Whichard ZL; Corey SJ
Cancer Lett; 2012 Jul; 320(1):104-10. PubMed ID: 22306341
[TBL] [Abstract][Full Text] [Related]
20. Genetic depletion and pharmacological targeting of αv integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models.
Li Y; Drabsch Y; Pujuguet P; Ren J; van Laar T; Zhang L; van Dam H; Clément-Lacroix P; Ten Dijke P
Breast Cancer Res; 2015 Feb; 17(1):28. PubMed ID: 25849225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]